Conflict of interest at the FDA, Part Deux: The tobacco advisory panel, well-stocked with ideologically devoted anti-harm reduction membership, could not determine that snus is less harmful than smoking. Shame!
Since its inception in 2010, the FDA s Tobacco Products Scientific Advisory Committee (TPSAC) has been populated by highly conflicted experts. Although it s powerless, still some rules need following. Federal Judge Leon agrees; FDA s Zeller does not.
